Improving the affinity of an antibody for its antigen via long-range electrostatic interactions

被引:25
作者
Fukunaga, Atsushi [1 ,2 ]
Tsumoto, Kouhei [1 ,3 ,4 ]
机构
[1] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan
[2] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 8128582, Japan
[3] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan
[4] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan
关键词
electrostatic interaction; refolding; scFv; SPR; troponin; ANTI-CD22; IMMUNOTOXIN; PHAGE DISPLAY; LIGHT-CHAINS; SPECIFICITY; MATURATION; PROTEOMICS; SELECTION; SEGMENTS; DESIGN; SITES;
D O I
10.1093/protein/gzt053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To address how long-range electrostatic force can affect antibodyantigen binding, we focused on the interactions between human cardiac troponin I and its specific single-chain antibodies (scFvs). We first isolated two scFvs against two linear epitopes with distinct isoelectric points. For the scFv against the acidic epitope (A1scFv), we mutated five residues of framework region 3 of the light chain to Lys or Arg, designated as the K- or R-mutant, respectively. For the scFv against the basic epitope (A2scFv), we mutated four or three residues in framework region 3 of the light or heavy chain to Asp, to generate the VL- and VH-mutant, respectively. Surface plasmon resonance analyses showed that the k(on) values of all of the mutants were greater than that of wild type, even though framework region 3 does not make direct contact with the epitope. The affinity of the K-mutant was pM range, and that of the R-mutant improved further by more than two orders of magnitude due to a decrease in the dissociation rate constant. For the A2scFv mutants, the affinity of the VL-mutant for its target improved through an increase in the k(on) value without a decrease in the k(off) value. The stability slightly decreased in all mutants. These results suggest that introducing electrostatic interaction can improve the affinity of an antibody for its target, even if the mutation reduces stability of the antibody.
引用
收藏
页码:773 / 780
页数:8
相关论文
共 26 条
[1]   Probing the binding mechanism and affinity of tanezumab, a recombinant humanized anti-NGF monoclonal antibody, using a repertoire of biosensors [J].
Abdiche, Yasmina Noubia ;
Malashock, Dan Stephen ;
Pons, Jaume .
PROTEIN SCIENCE, 2008, 17 (08) :1326-1335
[2]  
Adams GP, 1998, CANCER RES, V58, P485
[3]   Selection and analysis of an optimized anti-VEGF antibody: Crystal structure of an affinity-matured Fab in complex with antigen [J].
Chen, Y ;
Wiesmann, C ;
Fuh, G ;
Li, B ;
Christinger, HW ;
McKay, P ;
de Vos, AM ;
Lowman, HB .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 293 (04) :865-881
[4]  
Colcher D, 1998, Q J NUCL MED, V42, P225
[5]   THE DE-NOVO DESIGN OF AN ANTIBODY COMBINING SITE - CRYSTALLOGRAPHIC ANALYSIS OF THE V-L DOMAIN CONFIRMS THE STRUCTURAL MODEL [J].
ESSEN, LO ;
SKERRA, A .
JOURNAL OF MOLECULAR BIOLOGY, 1994, 238 (02) :226-244
[6]   An engineered IN-1Fab fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity [J].
Fiedler, M ;
Horn, C ;
Bandtlow, C ;
Schwab, ME ;
Skerra, A .
PROTEIN ENGINEERING, 2002, 15 (11) :931-941
[7]   In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxin [J].
Ho, M ;
Kreitman, RJ ;
Onda, M ;
Pastan, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) :607-617
[8]   Natural and designer binding sites made by phage display technology [J].
Hoogenboom, HR ;
Chames, P .
IMMUNOLOGY TODAY, 2000, 21 (08) :371-378
[9]   Engineering Anti-vascular Endothelial Growth Factor Single Chain Disulfide-stabilized Antibody Variable Fragments (sc-dsFv) with Phage-displayed sc-dsFv Libraries [J].
Huang, Yi-Jen ;
Chen, Ing-Chien ;
Yu, Chung-Ming ;
Lee, Yu-Ching ;
Hsu, Hung-Ju ;
Ching, Anna Tung Ching ;
Chang, Hung-Ju ;
Yang, An-Suei .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (11) :7880-7891
[10]   Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives [J].
Jackson, H ;
Bacon, L ;
Pedley, RB ;
Derbyshire, E ;
Field, A ;
Osbourn, J ;
Allen, D .
BRITISH JOURNAL OF CANCER, 1998, 78 (02) :181-188